Piramal Pharma Solutions Enhances Formulation Capabilities
Piramal Pharma Solutions, a leader in the Contract Development and Manufacturing Organization (CDMO) sector, recently made an impressive addition to its operations. The company has installed a cutting-edge Korsch XM-12 bilayer tablet press at its facility in the UK. This advancement is significant as it allows the facility's Formulation Development Team to have a critical tool for developing fixed-dose combinations and modified-release drug delivery systems.
Importance of the Korsch XM-12 Tablet Press
The Korsch XM-12 is a state-of-the-art device designed to produce high-quality tablets efficiently. This machine is especially beneficial for creating complex formulations that require precision and reliability. The tablet press's capability to handle varied drug delivery methods makes it a valuable asset within Piramal's operations.
Robust Training Initiatives for Safety and Quality
Piramal Pharma Solutions has implemented thorough training protocols to ensure that all personnel are well-prepared to operate the XM-12 safely. This emphasis on training guarantees that the machine will produce high-quality tablets consistently, which aligns with the company’s commitment to excellence.
The Role of the UK Facility
The facility in the UK, specifically in Morpeth, serves as a pivotal hub for Piramal Pharma Solutions. It offers specialized services that are essential for the development and manufacture of oral solids and hormonal products. By integrating innovative technology like the Korsch XM-12, the facility enhances its capacity to deliver superior products to clients globally.
Future of Formulation Development
The introduction of the Korsch XM-12 tablet press is just one of the many steps Piramal Pharma Solutions is taking to position itself at the forefront of the pharmaceutical industry. As the sector continues to evolve, the company remains committed to advancing its capabilities in formulation development to meet the changing demands of its customers.
Sustainability and Innovation in Pharma
Piramal Pharma Solutions also emphasizes sustainability alongside innovation. The adoption of advanced technologies ensures efficient use of resources and reduction of waste during the manufacturing process. The Korsch XM-12 tablet press aligns with this vision by providing a high degree of operational efficiency, ultimately leading to a sustainable boundary in drug formulation.
Frequently Asked Questions
What is the significance of the Korsch XM-12 tablet press?
The Korsch XM-12 tablet press enhances the capability of producing complex drug formulations, enabling the development of fixed-dose combinations and modified-release delivery systems.
How does Piramal ensure safety in operation?
Piramal implements robust training protocols for its employees to ensure safe operation of the tablet press and maintain high-quality output throughout the manufacturing process.
Where is the new tablet press located?
The Korsch XM-12 tablet press is located at Piramal's UK facility in Morpeth, which specializes in the development and manufacturing of various oral solids and hormonal products.
What role does the Morpeth facility play?
The Morpeth facility is essential for Piramal's operations, providing specialized services for oral solid formulations and hormonal products, enhancing the company's overall capabilities.
What are Piramal's goals with this new acquisition?
Piramal aims to improve its formulation development capabilities and elevate its position in the pharmaceutical market through the acquisition of advanced equipment like the Korsch XM-12 tablet press.
